|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
549,884 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,489,672 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
797,417 |
|
|
Total
Value |
$65,428,521 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
-5.8%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2024-06-12 |
18,323 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-08-16 |
16,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
855 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-04 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
21,642 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-30 |
4 |
AB |
$6.92 |
$17,664 |
D/D |
2,553 |
17,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-02 |
4 |
AS |
$16.36 |
$24,647 |
D/D |
(1,500) |
15,142 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-03 |
4 |
AS |
$16.70 |
$251,807 |
D/D |
(15,000) |
17,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-03 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
32,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-21 |
4 |
AS |
$18.54 |
$37,123 |
D/D |
(2,000) |
15,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-01 |
4 |
AS |
$18.18 |
$183,293 |
D/D |
(10,000) |
13,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-01 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
25,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-04 |
4 |
AS |
$18.38 |
$45,962 |
D/D |
(2,500) |
13,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-25 |
4 |
AS |
$17.65 |
$44,125 |
D/D |
(2,500) |
10,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-07-05 |
4 |
AS |
$18.21 |
$36,582 |
D/D |
(2,000) |
8,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-03 |
4 |
AS |
$18.00 |
$36,053 |
D/D |
(2,000) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-10 |
4 |
OE |
$6.46 |
$231,824 |
D/D |
35,886 |
42,581 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-10 |
4 |
S |
$20.20 |
$724,917 |
D/D |
(35,886) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-17 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-17 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-19 |
4 |
AS |
$23.00 |
$230,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-19 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-25 |
4 |
AS |
$24.00 |
$240,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-25 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-28 |
4 |
AS |
$25.00 |
$480,175 |
D/D |
(19,207) |
7,488 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-28 |
4 |
OE |
$6.46 |
$124,077 |
D/D |
19,207 |
25,902 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-01 |
4 |
AS |
$25.10 |
$19,904 |
D/D |
(793) |
6,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-01 |
4 |
OE |
$6.46 |
$5,123 |
D/D |
793 |
26,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-31 |
4 |
AB |
$6.92 |
$3,584 |
D/D |
518 |
7,213 |
0 |
- |
|
855 Records found
|
|
Page 2 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|